Navigation Links
Mindray Announces First Quarter 2009 Financial Results
Date:5/11/2009

748 846 Exhibit 3 MINDRAY MEDICAL INTERNATIONAL LIMITED RECONCILIATIONS OF NON-GAAP RESULTS OF OPERATIONS MEASURES TO THE NEAREST COMPARABLE GAAP MEASURES (Dollars in thousands, except for share and per share data) Three months ended March 31, 2008 2009 (unaudited) (unaudited) Net revenues 87,428 134,165 Non-GAAP net income 27,825 30,510 Non-GAAP net margin 31.8% 22.7% Amortization of acquired intangible assets (657) (2,208) Deferred tax impact related to acquired intangible assets 118 104 Termination payments -- (84) Share-based compensation (2,234) (2,981) GAAP net income 25,052 25,341 GAAP net margin 28.7% 18.9% Non-GAAP income per share - basic 0.26 0.28 Non-GAAP income per share - diluted 0.25 0.27 GAAP income per share - basic 0.23 0.23 GAAP income per share - diluted 0.22 0.23 Shares used in computation of: Basic earnings per share 106,962,659 107,872,202 Diluted earnings per share 112,998,260 112,118,964 Non-GAAP operating income
'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
3. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
4. Mindray Announces Option Exchange Offer
5. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
6. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
7. Mindray Announces Preliminary 2008 Operating Results
8. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
9. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
10. Mindray Announces 2008 Third Quarter and Nine Months Results
11. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... -- Sutter Health, a family of doctors, not-for-pr...ders, is donating $255,000 to food banks across No...ill share the quarter-million-dollar donation to h...ds of families across the north state. ,, Sut...nd supporting charitable programs and services. Th...
(Date:11/9/2009)... inhibit estrogen, , , MONDAY, Nov. 9 (...cancer and osteoporosis eliminated cervical cancer... also cleared precancerous growths in the cervix a...ce with precancerous lesions. , The breast canc...osis drug raloxifene were given to mice geneticall...
(Date:11/9/2009)...ons are age-related, researchers say , ,...ry doesn,t appear to speed the progression of age-... new study that challenges the belief that treatin... "Because both conditions are strongly age-related...rote Li Ming Dong, of Stony Brook University Schoo...
(Date:11/9/2009)...stCall/ - Hard To Treat Diseases (HTDS.PK) www.ht...S$41 billion international healthcare company, is ...er, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.... begin a five-year, $1 billion China initiative wi...e its investment in its China R&D facility, an...
(Date:11/9/2009)...rk (NCCN) has posted a draft white paper for publi...erm comparative effectiveness clinical evaluations... the NCCN Comparative Therapeutic Index(TM) (CTI),...versus-benefit of different treatment options reco...n Oncology(TM). The paper will be posted for publi...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...f news for working couple in India. A study in the...r a year or more tended// to become disruptive in ...e. The finding held up regardless of the chil...te of Child Health and Human Development, recruite...
...rganization (WHO) has approved four new drugs manu... tuberculosis, agency reports say//. And one of th...sistant to standard treatment. The addition ... The medicines are the first TB products to be ad...
..., researchers are discovering that some foods and ...ntion of the modern// world’s deadliest killer- th...erican Chemical Society, a one-day symposium, more...ing cancer of the esophagus, colon — Using animal ...
...he University of California have found out that or... than the ones that are grown// under conventional...agazine Chemistry & Industry. UK environment secre...Amodio and Adel Kader, showed that organically gro...
...iversity of Wisconsin-Madison claim that they can ...eaving out healthy cells//. This is very similar t...ell from another. The new tumor targeting stra...ies and immune responses. "The killing agent we ch...
...Ministry of Thailand plans to set up 21 community ...to relieve the heavy workload of provincial// hosp...ing with patients. The project estimated to c...vongvirot has said that 13 centres will be built i...
Other Medicine News:Health News:Poor Behavior Is Linked to Time in Day Care 2Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:Emboldened Warriors-Cancer Fighting Foods 2Health News:Emboldened Warriors-Cancer Fighting Foods 3Health News:organic kiwifruits promote health 2Health News:Tumors Targeted Naturally 2Health News:Tumors Targeted Naturally 3Health News:Hospital Projects to Take the Weight Off Overcrowded Ones 2
(Date:11/9/2009)...9 Landauer, Inc. (NYSE...ronmental radiation monitoring services, today ann...dance with its long-term strategic priorities. ,... Global Physics Solutions, Inc. (GPS) and Gammadat...nt and CEO of Landauer. "These acquisitions positi...
(Date:11/9/2009).../PRNewswire-Asia-FirstCall/ -- American Oriental,B...or "AOBO"), a pharmaceutical,company dedicated to ...ure and,commercialization of a broad range of pres...day announced that it plans to release third quart...2009, after the market closes. , The Comp...
(Date:11/9/2009)...ewswire/ -- Patent attorneys Cheryl Liljestrand, P...ill showcase Stipkala LLC at the Texas Life Scienc...eld at the Institute of Molecular Medicine in Hous...es a platform for cutting-edge companies to introd...ill feature keynote addresses and panel discussion...
Breaking Medicine Technology:Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 1Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 2Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 3Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 1Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 2Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 3Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 4Taking Aim at Relapse of Leukemia in Kids 49267 1Taking Aim at Relapse of Leukemia in Kids 49267 2
...ta ASA (OSE: ALGETA), the,Norwegian cancer therape...ind Bruland, of the Norwegian Radium Hospital, Osl... Discussion entitled,"Radium-223 in the treatment...(HRPC): Results from a randomized,placebo-control...linical Oncology,s annual meeting (1-5 June 2007, ...
...7- Results from various,clinical studies including...ed hepatocellular carcinoma, or primary liver canc...ted at the Annual,Meeting of the American Society ...une 1 - 5, 2007. , On this occasion a conference c...e 4, 2007. Starting at around 2:00 p.m. CEST,(12:0...
Other Medicine Technology:Algeta to Present Phase II Clinical Study Data for Alpharadin in,Prostate Cancer at ASCO 2
...able laparoscopic 12 mm linear cutting stapler for...ium staples., ,The stapler places two triple, sta... the knife divides the tissue in between. The inst...e surgical procedure: it can be reloaded up to 7 t...
...g unit for reloadable rotating (360°) linear s...tion and anastomosis with titanium staples., ,The...nium staples and simultaneously the knife divides ...for multiple use during a single surgical procedur...
ENDO GIA ROTICULATOR™ (Single Use Loading Units (SULU's) with Titanium Staples)
... Thoracic Endoscopic Linear Cutter has application...urgical procedures for transection, resection, and...taple line buttressing materials such as bovine pe... for a total of eight firings. Different cartridge...
Medicine Products: